News: 20192019-05-24T15:41:39+00:00

News: 2019

Shore Capital Announces Formation of Southern Ear, Nose, Throat, and Allergy Partners

May 17, 2019 ‐ Shore Capital Partners (“Shore Capital” or “Shore”) is pleased to announce that it has formed Southern Ear, Nose, Throat and Allergy Partners (“SENTA”) and completed a strategic partnership with Northwest ENT and Allergy Center (“Northwest ENT” or the “Company”). Northwest ENT is a leading ear, nose and throat (“ENT”) and allergy services provider with seven locations including two affiliated ambulatory surgery centers in the Greater Atlanta, Georgia metro area. The Company offers comprehensive medical and surgical ENT and allergy services, including treatment for thyroid disorders, sinus conditions, ear pain, allergies, and throat disorders. Northwest ENT will continue to [...]

Shore Capital Announces Closing of HC Fund III and F&B Fund I

April 17, 2019 ‐ Shore Capital Partners (“Shore” or the “Firm”), a strategic private equity firm focused on the healthcare and food & beverage industries, announced the first and only closings of its third institutional healthcare private equity fund, Shore Capital Healthcare Partners Fund III (“HC Fund III”), and its inaugural food & beverage fund, Shore Capital Food & Beverage Partners Fund I (“F&B Fund I”). HC Fund III raised $293 million, while F&B Fund I raised $148 million. With these respective closings, Shore now manages a total committed capital base of more than $1 billion. HC Fund III surpassed its original [...]